ACTA MEDICA, Vol 56 No 1 (2013), 36–38
Efficacy of Topiramate as Add-on Therapy in Two Different Types of Progressive Myoclonic Epilepsy
Caner Feyzi Demir, Hasan Hüseyin Özdemir, Bülent Müngen
DOI: https://doi.org/10.14712/18059694.2014.37
zveřejněno: 23. 07. 2015
Abstract
The present article describes two unrelated cases of progressive myoclonic epilepsy (PME) of the Lafora’s disease and Unverricht-Lundborg types who were treated with topiramate (TPM) as add-on therapy for their myoclonus. After the initiation of topiramate therapy both cases responded with marked decrease in myoclonic seizure frequency and improvement of quality of life. Topiramate appears to be a useful alternative agent in cases of PME and could be consider for adjunctive therapy.
klíčová slova: Progressive myoclonic epilepsy; Topiramate
Efficacy of Topiramate as Add-on Therapy in Two Different Types of Progressive Myoclonic Epilepsy is licensed under a Creative Commons Attribution 4.0 International License.
210 x 297 mm
vychází: 4 x ročně
cena tištěného čísla: 150 Kč
ISSN: 1211-4286
E-ISSN: 1805-9694